Precigen Inc (PGEN)
1.305
-0.02
(-1.88%)
USD |
NASDAQ |
Apr 19, 12:22
Precigen Cash from Financing (TTM): 29.59M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 29.59M |
September 30, 2023 | -9.693M |
June 30, 2023 | -125.43M |
March 31, 2023 | -110.96M |
December 31, 2022 | -155.29M |
September 30, 2022 | -116.12M |
June 30, 2022 | -0.152M |
March 31, 2022 | -0.016M |
December 31, 2021 | 121.19M |
September 30, 2021 | 121.22M |
June 30, 2021 | 120.88M |
March 31, 2021 | 119.59M |
December 31, 2020 | 32.70M |
September 30, 2020 | 58.54M |
June 30, 2020 | 58.70M |
March 31, 2020 | 59.93M |
December 31, 2019 | 32.70M |
September 30, 2019 | 34.19M |
June 30, 2019 | 227.74M |
March 31, 2019 | 228.46M |
December 31, 2018 | 309.80M |
September 30, 2018 | 296.25M |
June 30, 2018 | 95.97M |
Date | Value |
---|---|
March 31, 2018 | 95.69M |
December 31, 2017 | 4.284M |
September 30, 2017 | -8.517M |
June 30, 2017 | -7.559M |
March 31, 2017 | -0.673M |
December 31, 2016 | 12.06M |
September 30, 2016 | 11.40M |
June 30, 2016 | 230.18M |
March 31, 2016 | 230.62M |
December 31, 2015 | 331.68M |
September 30, 2015 | 332.85M |
June 30, 2015 | 116.42M |
March 31, 2015 | 109.45M |
December 31, 2014 | 24.00M |
September 30, 2014 | 23.07M |
June 30, 2014 | 195.44M |
March 31, 2014 | 278.60M |
December 31, 2013 | 316.45M |
September 30, 2013 | 341.17M |
June 30, 2013 | 172.37M |
March 31, 2013 | 96.81M |
December 31, 2012 | 75.94M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-155.29M
Minimum
Dec 2022
227.74M
Maximum
Jun 2019
26.28M
Average
32.70M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
Cyclacel Pharmaceuticals Inc | 0.848M |
HealthEquity Inc | -47.04M |
Corvus Pharmaceuticals Inc | 7.855M |
Oragenics Inc | 0.2839M |
MAIA Biotechnology Inc | 9.271M |